Company
Eyebright Medical Technology
Headquarters: Beijing, China
Employees: 503
Market Cap
CN¥13.18 Billion
CNY as of July 1, 2025
US$1.84 Billion
Eyebright Medical Technology Categories
China Healthcare Medical Instruments & SuppliesChina Healthcare China Medical Instruments & Supplies
Top Competitors by Market Capitalization
Industry: Medical Instruments & Supplies
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $193.76 B |
| EssilorLuxottica SA | $128.90 B |
| Becton, Dickinson and Company | $50.81 B |
| Alcon Inc. | $44.33 B |
| HOYA Corp | $40.30 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
Eye Bright Medical Technology Co., Ltd. develops a range of ophthalmic medical products. Its products include surgical implants and instruments, equipment, optometric lenses, eye drops, etc. for the treatment of ophthalmic diseases and vision problems, such as cataract, glaucoma, refractive errors, and other ophthalmic diseases. The company was founded in 2010 and is based in Beijing, China.
Financials
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | CN¥1.46 B |
| EBITDA | CN¥456.6 M |
| Gross Profit TTM | CN¥938.7 M |
| Profit Margin | 25.95% |
| Operating Margin | 29.83% |
| Quarterly Revenue Growth | 15.10% |
Stocks & Indices
Eyebright Medical Technology has the following listings and related stock indices.
Stock: SSE: 688050 wb_incandescent